gabapentin

Generic: gabapentin

Labeler: aci healthcare usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler aci healthcare usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 300 mg/1

Manufacturer
ACI Healthcare USA, Inc.

Identifiers & Regulatory

Product NDC 71093-121
Product ID 71093-121_a916797c-381c-4008-b778-19221233ef45
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206943
Listing Expiration 2026-12-31
Marketing Start 2018-05-14

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71093121
Hyphenated Format 71093-121

Supplemental Identifiers

RxCUI
310430 310431 310432
UPC
0371093122048 0371093120051
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA206943 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-04)
  • 500 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-05)
source: ndc

Packages (2)

Ingredients (1)

gabapentin (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a916797c-381c-4008-b778-19221233ef45", "openfda": {"nui": ["N0000008486"], "upc": ["0371093122048", "0371093120051"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["7538e255-95df-4991-aae0-a90d709f1e95"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["ACI Healthcare USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-04)", "package_ndc": "71093-121-04", "marketing_start_date": "20180804"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-05)", "package_ndc": "71093-121-05", "marketing_start_date": "20180804"}], "brand_name": "Gabapentin", "product_id": "71093-121_a916797c-381c-4008-b778-19221233ef45", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71093-121", "generic_name": "Gabapentin", "labeler_name": "ACI Healthcare USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA206943", "marketing_category": "ANDA", "marketing_start_date": "20180514", "listing_expiration_date": "20261231"}